ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

05 Dec 2024

ECO Animal Health - HY Results - Investor Presentation video - 4 December 2024

David Hallas (CEO) and Chris Wilks (CFO) of ECO Animal Health conducted an Investor Presentation covering their Interim Results for the period to 30th September 2024.

Management discussed the measures to protect profitability despite the fall in Aivlosin® revenues, while also exploring the factors behind good growth in the Americas and new Aivlosin® claims approved in the period. The team discussed progression of the R&D pipeline, detailing time to market in their six key projects. Management provided a detailed overview of key financial performance, and answered a range of questions submitted by viewers.

The full video is available to watch, divided into chapters as below:
0:00:03 Beginning
0:01:19 Highlights of the period, including Financial Highlights
0:04:47 Detailed review of Financials
0:18:34 Overview of Pipeline Assets
0:23:55 ECO values, and global opportunities
0:28:06 Conclusion & Outlook
0:28:59 Questions & Answers

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge